Form D · Biotechnology

Judo Bio Inc.

Cambridge, MA · CIK 0001955569

Offering snapshot reported Aug 16, 2024 · SEC filing

Reported sold
$25M
Indefinite offering
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 31, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 16, 2024Initial$25,000,000No comparison21SEC filing
Jun 3, 2024Initial$5,000,000No comparison2SEC filing
Nov 21, 2023Amendment$25,000,000$5,000,000vs Nov 22, 20222SEC filing
Nov 22, 2022Initial$20,000,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-521812

Source: Form D, filed Aug 16, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kevin Bitterman Director, Executive
Sam Bjork Director
Ommer Chohan Executive
Robert Gaffey Executive
James Jeffrey Goater Director, Executive
George Golumbeski Director
Chelsea Place Johnson Director
Ankit Mahadevia Director
Hui Tian Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
300 Technology Square 8 Th Floor
Cambridge, MA, 02139